ERG and myeloid leukemia: The androgen-responsive promotor region of the TMPRSS2 gene drives robust expression of ERG, an oncogene that is also frequently involved in chromosomal translocations in Ewing sarcoma, myeloid leukemia and cervical carcinoma [56], [57], [58].